Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period (TSPedCovid)

May 15, 2026 updated by: Hospices Civils de Lyon

Clinical and Socioeconomic Characteristics of Suicidal Behaviour in Children and Adolescents During the Covid19 Pandemic Period in Auvergne-Rhône-Alpes. Prospective Quantitative and Qualitative Study

In 2020, the world is hit by a global health crisis due to a pandemic following the appearance of Sars-cov-2 or "covid-19". This pandemic was accompanied by a constant fear of contamination and death, relayed by the media. In France, the government proposed in response to the arrival of this virus on French territory. This policy was implemented in different ways over 3 distinct periods: strict containment at the start of the epidemic, then a "lighter" one, and finally a period of social restrictions without between these periods. This policy had a direct and rapid impact on the population's daily routines. Children and adolescents, are more susceptible to psychological trauma, as stress has a direct and psychic development. Studies have shown deleterious impact of the French health situation on the paediatric population. They point to an increase of psychological disorders such as depression and anxiety in the under -20s population, and an increase in suicidal gestures over the 2020-2021 period, with rates remaining higher than in previous years. Suicide is the 2nd leading cause of death in the population aged 15-24.

Studies continue to focus on the incidence of suicidal gestures of suicidal gestures and psychological disorders, and few of them examine the factors linked to the increase in these incidences, the traumatic impact or the story of the trajectory. Similarly, the few studies focus only on the population aged 12 and over, and in some cases, do not distinguish between age groups (15-24 or under 20).

Investigators believe that the various periods of social restrictions and eco-anxiety caused by the pandemic may have influenced suicidal behaviour in this population.

The main objective of this study is to investigate the clinical and socio-economic characteristics of the pediatric population who experienced suicidal behaviors in the Auvergne Rhone Alpes region during the covid 19 pandemic.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

6500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bron, France, 69500
        • Recruiting
        • Hospices Civils de Lyon - Hôpital Femme Mère Enfant- Service de pédopsychiatrie de l'enfant et de l'adolescent
        • Contact:
        • Principal Investigator:
          • Elise MAMIMOUE, Dr
      • Clermont-Ferrand, France, 63000
        • Not yet recruiting
        • CHU de Clermont-Ferrand - Service de psychiatrie de l'enfant et de l'adolescent
        • Contact:
        • Principal Investigator:
          • Jonathan LACHAL, Pr
      • Grenoble, France, 38043
        • Not yet recruiting
        • CHU de Grenoble - Service de psychiatrie de l'enfant et de l'adolescent
        • Principal Investigator:
          • Stéphanie BIOULAC, Dr
        • Contact:
      • Saint-Etienne, France, 42100
        • Not yet recruiting
        • CHU de Saint-Etienne - Urgences psychiatriques
        • Contact:
        • Principal Investigator:
          • Catherine Massoubre, Pr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The population (subjects and controls) will be divided into age categories:

    • Pre-adolescents (≥ 8 years and < 11 years)
    • Adolescents (≥ 11 years and < 15 years)
    • Older adolescents (≥ 15 years and < 18 years)

Subjects with suicidal behavior during the health crisis (Group 1):

  • Age > 8 years and < 18 years during the period 2020 to 2022.
  • Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).

Subjects with suicidal behavior during the health crisis with qualitative interviews (Group 1b):

  • Age > 8 years and < 18 years during the period 2020 to 2022.
  • Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
  • Randomly selected from the population of Group 1.
  • For whom the parent(s) and/or the subject have signed informed consent.

Controls with suicidal behavior before the health crisis (Group 2):

  • Age > 8 years and < 18 years during the period 2018 to 2019.
  • Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2018 and/or 2019 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).

Exclusion Criteria:

- Subjects with Suicidal Behavior during the Health Crisis with and without Qualitative Interviews (Group 1 and 1b):

• Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2020 to 2022.

Controls with Suicidal Behavior before the Health Crisis (Group 2):

  • Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2018 to 2019.
  • Intercurrent illness with a life expectancy of less than 24 hours.

For Group 1:

  • Pregnant, postpartum, or breastfeeding women.
  • Persons deprived of liberty by judicial or administrative decision.
  • Adults subject to a legal protection measure (guardianship, curatorship).
  • Persons not affiliated with a social security scheme or beneficiaries of a similar scheme.
  • Persons who do not understand and do not speak French.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Subjects with suicidal behaviors during the health crisis of covid-19 between 2020 and 2022 (group1)
  • Name : Group 1
  • Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022.
  • Age ≥ 8 years old and < 18 years old between 2020 and 2022.
The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.
Experimental: Subjects with suicidal behaviors during covid-19 period with qualitative interviews (group 1b)
  • Name : Group 1b
  • Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022 and theirs parents
  • Age ≥ 8 years old and < 18 years old between 2020 and 2022 for subjects.
  • One or both parents
  • Subjects who agreed to participate in interviews and/or focus groups and gave their consent to be part of the group of patients participating in a qualitative interview (volunteer subjects).
  • Parent's subjects agreed their consent to be part of the group This group is estimated to 150 subjects and 300 parents max.
The psychopathological and socioeconomic characteristics will be collected. For subjects who agreed, they will participate in interviews and/or focus groups. Parent's subjects who agreed will be part of focus groups too.
Experimental: Subjects control with suicidal behaviors before the health crisis (Group 2).
  • Name: group 2
  • Subjects with suicidal behaviors (suicidal conduct, ideas, self-harm with suicidal intention) before the health crisis of Covid-19 (2018 and or 2019) and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region
  • Age ≥ 8 years old and < 18 years old between 2018 and 2019
The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic and diagnostic characteristics
Time Frame: Baseline

The following demographic and diagnostic characteristics will be collected in aggregate form for the entire population of children and adolescents who engaged in suicidal behavior during the health crisis and in the two preceding years:

  • Age, gender, place of residence,
  • ICD-10 diagnosis and referral,
  • Type of suicidal behavior (ideation, self-harm, suicide attempt),
  • Periods of social restrictions (lockdown, curfew, vaccine pass).
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients aged 8-17 and 11month admitted to pediatric emergency
Time Frame: Baseline
Number of patients aged 8-17 and 11month admitted to pediatric emergency rooms or hospitalized in a continuous care/intensive care unit of university hospitals (CHU) or general hospitals (CH) for suicidal behavior during the COVID-19 pandemic period of 2020, 2021, and 2022, and those in the two preceding years: 2018 and 2019.
Baseline
Psychopathological and socio-economic characteristics
Time Frame: Baseline

The following psychopathological and socio-economic characteristics will be collected:

  • Age, sex, place of residence,
  • Family situation and intrafamilial relationships
  • Type of suicidal behavior and description (ideation, self-harm, suicide attempt)
  • Periods of social restrictions (lockdown, curfew, vaccination pass)
  • Leisure time and type of leisure activities/hobbies
  • Education
  • Relationship with peers
  • Previous and current psychiatric diagnosis (according to ICD-10)
  • Personal and family psychiatric history
  • Personal medical history
  • Pharmacological and psychological treatment; Type of care
Baseline
Scores to CRIES
Time Frame: Up to 3 months
Scores on the Children's Revised Impact of Events Scale (CRIES-13) (Horowitz et al., 1979; Brunet et al., 2003) among children from a representative sample of the cohort (group 1b, volunteer subjects).
Up to 3 months
CAS scale
Time Frame: Up to 3 months
Scores on the Climate Anxiety Scale (CAS) (Clayton and Karazsia, 2020; Mouguiama-Daouda et al., 2022) among children from a representative sample of the cohort (group 1b, volunteer subjects).
Up to 3 months
Qualitative interview
Time Frame: Up to 3 months

Semi-structured interviews with children and adolescents with suicidal behavior from a representative sample of the cohort.

Subjects who agreed to interviews. We will try to have a sample of volunteers from Group 1 who can be representative of our population (care orientation, age, personal psychiatric history, and place of residence.)

Up to 3 months
Results to focus groups (parent's subjects, group 1b)
Time Frame: Up to 3 months
Focus groups with the parents of children and adolescents with suicidal behavior from a representative sample of the cohort (randomly selected).
Up to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2026

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

February 1, 2028

Study Registration Dates

First Submitted

November 24, 2025

First Submitted That Met QC Criteria

December 10, 2025

First Posted (Actual)

December 24, 2025

Study Record Updates

Last Update Posted (Actual)

May 18, 2026

Last Update Submitted That Met QC Criteria

May 15, 2026

Last Verified

May 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicidality

Clinical Trials on Aggregated data collection

Subscribe